{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=BNT162b2+Vaccine", "query": { "intervention": "BNT162b2 Vaccine" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 57, "total_pages": 6, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=BNT162b2+Vaccine&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-21T16:46:00.768Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05047640", "title": "COVID-19 3rd Dose Vaccine in Transplant Patients", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Covid19" ], "interventions": [ { "name": "BNT162b2 vaccine", "type": "BIOLOGICAL" }, { "name": "JNJ-78436735 Vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Giselle Guerra", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 58, "start_date": "2021-09-14", "completion_date": "2022-10-25", "has_results": true, "last_update_posted_date": "2024-06-04", "last_synced_at": "2026-09-21T16:46:00.768Z", "location_count": 1, "location_summary": "Miami, Florida", "locations": [ { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05047640" }, { "nct_id": "NCT04816669", "title": "A Study to Evaluate Safety, Tolerability, & Immunogenicity of Multiple Formulations of BNT162b2 Against COVID-19 in Healthy Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "SARS-CoV-2 Infection", "COVID-19" ], "interventions": [ { "name": "BNT162b2", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "BioNTech SE", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 629, "start_date": "2021-04-01", "completion_date": "2021-12-02", "has_results": true, "last_update_posted_date": "2022-12-23", "last_synced_at": "2026-09-21T16:46:00.768Z", "location_count": 21, "location_summary": "Anaheim, California • Walnut Creek, California • Hialeah, Florida + 16 more", "locations": [ { "city": "Anaheim", "state": "California" }, { "city": "Walnut Creek", "state": "California" }, { "city": "Hialeah", "state": "Florida" }, { "city": "Hollywood", "state": "Florida" }, { "city": "Jacksonville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04816669" }, { "nct_id": "NCT04368728", "title": "Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "SARS-CoV-2 Infection", "COVID-19" ], "interventions": [ { "name": "BNT162b1", "type": "BIOLOGICAL" }, { "name": "BNT162b2", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "OTHER" }, { "name": "BNT162b2SA", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "BioNTech SE", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 46969, "start_date": "2020-04-29", "completion_date": "2023-02-10", "has_results": true, "last_update_posted_date": "2026-03-25", "last_synced_at": "2026-09-21T16:46:00.768Z", "location_count": 154, "location_summary": "Athens, Alabama • Birmingham, Alabama • Huntsville, Alabama + 106 more", "locations": [ { "city": "Athens", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT04368728" }, { "nct_id": "NCT05997290", "title": "A Study to Learn About New COVD-19 RNA Vaccine Candidates for New Variants in Healthy Individuals", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "SARS-CoV-2 Infection", "COVID-19" ], "interventions": [ { "name": "BNT162b2 (Omi XBB.1.5)", "type": "BIOLOGICAL" }, { "name": "BNT162b2 (Omi JN.1)", "type": "BIOLOGICAL" }, { "name": "BNT162b2 (Omi KP.2)", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "BioNTech SE", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 1051, "start_date": "2023-08-10", "completion_date": "2025-03-13", "has_results": true, "last_update_posted_date": "2026-04-28", "last_synced_at": "2026-09-21T16:46:00.768Z", "location_count": 37, "location_summary": "Athens, Alabama • Huntsville, Alabama • Mobile, Alabama + 30 more", "locations": [ { "city": "Athens", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Surprise", "state": "Arizona" }, { "city": "Tempe", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT05997290" }, { "nct_id": "NCT04713553", "title": "A Phase 3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of Multiple Production Lots and Dose Levels of BNT162b2 RNA-Based COVID-19 Vaccines Against COVID-19 in Healthy Participants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "SARS-CoV-2 Infection", "COVID-19" ], "interventions": [ { "name": "BNT162b2", "type": "BIOLOGICAL" }, { "name": "BNT162b2.B.1.351", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "BioNTech SE", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "12 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "12 Years to 50 Years" }, "enrollment_count": 1574, "start_date": "2021-02-15", "completion_date": "2021-07-22", "has_results": true, "last_update_posted_date": "2022-12-22", "last_synced_at": "2026-09-21T16:46:00.768Z", "location_count": 17, "location_summary": "Oakland, California • Milford, Connecticut • Hialeah, Florida + 13 more", "locations": [ { "city": "Oakland", "state": "California" }, { "city": "Milford", "state": "Connecticut" }, { "city": "Hialeah", "state": "Florida" }, { "city": "Hollywood", "state": "Florida" }, { "city": "Orlando", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04713553" }, { "nct_id": "NCT06742281", "title": "A Phase 2b, Randomized, Double-blind, Active-controlled Study of Single Dose CVXGA Intranasal COVID-19 Vaccine in Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "COVID-19" ], "interventions": [ { "name": "CVXGA (CVXGA50)", "type": "BIOLOGICAL" }, { "name": "COMIRNATY®", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "CyanVac LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "100 Years", "sex": "ALL", "summary": "18 Years to 100 Years" }, "enrollment_count": 432, "start_date": "2024-12-05", "completion_date": "2026-06-15", "has_results": false, "last_update_posted_date": "2026-07-10", "last_synced_at": "2026-09-21T16:46:00.768Z", "location_count": 55, "location_summary": "Anniston, Alabama • Phoenix, Arizona • Chula Vista, California + 44 more", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Chula Vista", "state": "California" }, { "city": "La Mesa", "state": "California" }, { "city": "La Palma", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06742281" }, { "nct_id": "NCT04969263", "title": "COVID-19 Protection After Transplant Pilot Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Kidney Transplant Recipients" ], "interventions": [ { "name": "BNT162b2 vaccine (Pfizer/BioNTech)", "type": "BIOLOGICAL" }, { "name": "mRNA-1273 vaccine (Moderna)", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 81, "start_date": "2021-08-10", "completion_date": "2023-03-10", "has_results": true, "last_update_posted_date": "2025-07-30", "last_synced_at": "2026-09-21T16:46:00.768Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT04969263" }, { "nct_id": "NCT06919796", "title": "mRNA Covid-19 Vaccine Immune Response Comparisons Using Different Delivery Routes", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Evaluate Immune Responses Following mRNA COVID-19 Vaccine Administration Through Different Delivery Routes in Healthy Volunteers", "SARS CoV-2" ], "interventions": [ { "name": "COMIRNATY®", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "PharmaJet, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "18 Years to 50 Years" }, "enrollment_count": 40, "start_date": "2025-05-01", "completion_date": "2026-11-25", "has_results": false, "last_update_posted_date": "2025-04-15", "last_synced_at": "2026-09-21T16:46:00.768Z", "location_count": 1, "location_summary": "Decatur, Georgia", "locations": [ { "city": "Decatur", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT06919796" }, { "nct_id": "NCT07730450", "title": "A Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of Age", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "COVID-19 Vaccines" ], "interventions": [ { "name": "BNT162b2 Vaccine", "type": "BIOLOGICAL" }, { "name": "Tdap Vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "BioNTech SE", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "64 Years", "sex": "ALL", "summary": "18 Years to 64 Years" }, "enrollment_count": 200, "start_date": "2026-07-23", "completion_date": "2027-08-20", "has_results": false, "last_update_posted_date": "2026-08-07", "last_synced_at": "2026-09-21T16:46:00.768Z", "location_count": 5, "location_summary": "Walnut Creek, California • Miami Lakes, Florida • Honolulu, Hawaii + 2 more", "locations": [ { "city": "Walnut Creek", "state": "California" }, { "city": "Miami Lakes", "state": "Florida" }, { "city": "Honolulu", "state": "Hawaii" }, { "city": "Durham", "state": "North Carolina" }, { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT07730450" }, { "nct_id": "NCT06672055", "title": "A Study to Evaluate VXA-CoV2-3.3 COVID-19 Vaccine Against Currently Approved/Authorized mRNA COVID-19 Injectable Booster Vaccine in Adults Previously Immunized Against COVID-19 Infection", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "SARS-CoV2", "COVID-19" ], "interventions": [ { "name": "VXA-CoV2-3.1", "type": "BIOLOGICAL" }, { "name": "COMIRNATY®", "type": "BIOLOGICAL" }, { "name": "VXA-CoV2-3.3", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Vaxart", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 5485, "start_date": "2024-10-08", "completion_date": "2027-05", "has_results": false, "last_update_posted_date": "2026-06-25", "last_synced_at": "2026-09-21T16:46:00.768Z", "location_count": 145, "location_summary": "Anniston, Alabama • Birmingham, Alabama • Mobile, Alabama + 126 more", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Glendale", "state": "Arizona" }, { "city": "Mesa", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT06672055" } ] }